Literature DB >> 15888739

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer.

K M Tveit1, V V Kataja.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15888739     DOI： 10.1093/annonc/mdi827

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  Adjuvant therapies for colorectal cancer.

Authors:  Suzanne Kosmider; Lara Lipton
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

2.  Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases.

Authors:  Omar Hyder; Rebecca M Dodson; Skye C Mayo; Eric B Schneider; Matthew J Weiss; Joseph M Herman; Christopher L Wolfgang; Timothy M Pawlik
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

3.  Colon Cancer Staging in Vulnerable Older Adults: Adherence to National Guidelines and Impact on Survival.

Authors:  T B Leal; T Holden; L Cavalcante; G O Allen; J R Schumacher; M A Smith; J M Weiss; H B Neuman; N K LoConte
Journal:  Ann Hematol Oncol       Date:  2014

4.  Evaluation of a rabbit rectal VX2 carcinoma model using computed tomography and magnetic resonance imaging.

Authors:  Xin-Mei Liang; Guang-Yu Tang; Ying-Sheng Cheng; Bi Zhou
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

Review 5.  A systematic review of treatment guidelines for metastatic colorectal cancer.

Authors:  M S Edwards; S D Chadda; Z Zhao; B L Barber; D P Sykes
Journal:  Colorectal Dis       Date:  2012-02       Impact factor: 3.788

6.  Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial).

Authors:  Kiyotaka Okuno; Toru Aoyama; Koji Oba; Noboru Yokoyama; Nobuhisa Matsuhashi; Katsuyuki Kunieda; Yoji Nishimura; Hiroki Akamatsu; Takaya Kobatake; Satoshi Morita; Takaki Yoshikawa; Junichi Sakamoto; Shigetoyo Saji
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-01       Impact factor: 3.333
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.